Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wiggi

31.01.2022 - CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) - Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system ... Seite 1

Related Keywords

Michigan , United States , Sutro Biopharma , Bristol Myers Squibb , Cancer Research , Oncology For Early Clinical Research , Society For Immunotherapy Of Cancer , National Cancer Institute , Clinical Oncology At Merck Research Laboratories , Cullinan Oncology Inc , University Of Michigan , Senior Advisor , Cullinan Oncology , Medical Officer , Chief Medical Officer , Therapeutic Area Head , Early Clinical Research , Executive Medical Director , Group Medical Director , Discovery Medicine Clinical Oncology , Clinical Oncology , Merck Research , Investigational Biologics Section ,